written by reader Covid 19 info

By colonel, September 8, 2020

It may be of interest to you and other Gumshoe members regarding a new spray formulation for Covid 19 being developed by Starphama Holdings which has some unique and impressive results versus Remdesivir sensitivities and other antiviral indications. They were just awarded a million dollars by the Australian Government to assist in the development of the drugs commercialization prospects.
I have owned this companies stock for a few years due to their dendrimer product used in other indications. Thanks for all the in depth info you provide on other promoted stocks. Keith Nelson

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.



This site uses Akismet to reduce spam. Learn how your comment data is processed.

Inline Feedbacks
View all comments

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info